Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Thermo Fisher Scientific Inc (NYSE: TMO) closed at $562.39 in the last session, down -0.03% from day before closing price of $562.56. In other words, the price has decreased by -$0.03 from its previous closing price. On the day, 2.25 million shares were traded. TMO stock price reached its highest trading level at $569.27 during the session, while it also had its lowest trading level at $554.53.
Ratios:
We take a closer look at TMO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 59.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 34.58. For the most recent quarter (mrq), Quick Ratio is recorded 1.11 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.62.
On December 09, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $685.
KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on December 08, 2025, while the target price for the stock was maintained at $750.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 04 ’25 when Lagarde Michel sold 22,046 shares for $563.56 per share. The transaction valued at 12,424,244 led to the insider holds 84,117 shares of the business.
Lagarde Michel sold 32,000 shares of TMO for $18,668,526 on Dec 03 ’25. The Executive Vice President & COO now owns 65,480 shares after completing the transaction at $583.39 per share. On Dec 02 ’25, another insider, Lagarde Michel, who serves as the Executive Vice President & COO of the company, sold 30,000 shares for $581.92 each. As a result, the insider received 17,457,600 and left with 29,480 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMO now has a Market Capitalization of 211294470144 and an Enterprise Value of 243564462080. As of this moment, Thermo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.49, and their Forward P/E ratio for the next fiscal year is 22.85. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.83 while its Price-to-Book (P/B) ratio in mrq is 4.14. Its current Enterprise Value per Revenue stands at 5.569 whereas that against EBITDA is 22.479.
Stock Price History:
The Beta on a monthly basis for TMO is 0.92, which has changed by 0.073485374 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, TMO has reached a high of $610.97, while it has fallen to a 52-week low of $385.46. The 50-Day Moving Average of the stock is -0.79%, while the 200-Day Moving Average is calculated to be 16.47%.
Shares Statistics:
According to the various share statistics, TMO traded on average about 2.04M shares per day over the past 3-months and 1676120 shares per day over the past 10 days. A total of 375.71M shares are outstanding, with a floating share count of 374.82M. Insiders hold about 0.24% of the company’s shares, while institutions hold 91.81% stake in the company. Shares short for TMO as of 1764288000 were 5101544 with a Short Ratio of 2.50, compared to 1761868800 on 4409154. Therefore, it implies a Short% of Shares Outstanding of 5101544 and a Short% of Float of 1.3599999999999999.
Dividends & Splits
The forward annual dividend rate for TMO is 1.72, which was 1.68 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.002986348. The stock’s 5-year Average Dividend Yield is 0.24. The current Payout Ratio is 9.43% for TMO, which recently paid a dividend on 2025-12-15 with an ex-dividend date of 2025-12-15. Stock splits for the company last occurred on 1996-06-06 when the company split stock in a 3:2 ratio.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 21.0 analysts currently analyzing and rating the stock of Thermo Fisher Scientific Inc (TMO).The consensus estimate for the next quarter is $5.59, with high estimates of $5.84 and low estimates of $5.38.
Analysts are recommending an EPS of between $22.81 and $22.51 for the fiscal current year, implying an average EPS of $22.73. EPS for the following year is $24.65, with 27.0 analysts recommending between $25.87 and $24.0.
Revenue Estimates
According to 19 analysts,. The current quarter’s revenue is expected to be $11.95B. It ranges from a high estimate of $12.01B to a low estimate of $11.82B. As of. The current estimate, Thermo Fisher Scientific Inc’s year-ago sales were $11.39BFor the next quarter, 19 analysts are estimating revenue of $11.03B. There is a high estimate of $11.25B for the next quarter, whereas the lowest estimate is $10.87B.
A total of 25 analysts have provided revenue estimates for TMO’s current fiscal year. The highest revenue estimate was $44.44B, while the lowest revenue estimate was $43.71B, resulting in an average revenue estimate of $44.26B. In the same quarter a year ago, actual revenue was $42.88BBased on 25 analysts’ estimates, the company’s revenue will be $46.52B in the next fiscal year. The high estimate is $46.93B and the low estimate is $46.01B.
